News

Wegovy® is indicated for chronic weight management in adults and adolescents (12+) with obesity or overweight and at least ...
Following a visit to Copenhagen, Denmark, to collaborate on enhancing urban health, the Bangkok Metropolitan Administration (BMA) and Novo Nordisk will launch the Cities for Better Health (CBH) ...
In a recent panel conversation, healthcare and industry experts discussed where to find reliable guidance in a sea of ...
Hims & Hers will begin offering generic semaglutide drugs in Canada next year after Novo Nordisk lost its exclusive patent ...
Over 60 novel drug candidates are in late-stage clinical trials in China, and these will potentially compete directly with US ...
BENGALURU] European shares closed lower on Friday (Jul 11), as losses in banks and healthcare stocks weighed at the end of a ...
FRANKFURT: European shares closed lower on Friday, as losses in banks and healthcare stocks weighed at the end of ...
Opinion
Zacks Investment Research on MSN8hOpinion
Bull of the Day: Hims & Hers Health (HIMS)
Hims & Hers Health (HIMS) is quickly becoming one of the most compelling stories in the market as an emerging powerhouse in the direct-to-consumer healthcare space. The stock has posted outsized gains ...